Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Dry Eye > Ophthalmologists Share Best Practices for Explaining Demodex Blepharitis to Patients
  • Dry Eye

Ophthalmologists Share Best Practices for Explaining Demodex Blepharitis to Patients

Ophthalmology 360

This content was developed and is sponsored by Tarsus.

Four ophthalmologists were asked how they explain the diagnosis of Demodex blepharitis (DB) to their patients. They offer scripts and tips for addressing the symptoms patients are experiencing, explaining what the Demodex mites are and how they can effectively treat the condition with a twice-daily drop, Xdemvy (lotilaner ophthalmic solution 0.25%), an FDA-approved therapeutic.

Video #1: Dr. Ravi Patel

Ravi Patel, MD, MBA, of Atlantic Eye, offers a sample script for explaining Demodex blepharitis in understandable terms for patients.

 

 

Video #2: Dr. Julio Albarracin

Julio Albarracin, MD, of the Key-Whitman Eye Center, shares how he explains Demodex blepharitis to patients, offering a comparison of the mites on the eye as being similar to the bacteria and yeast found on the body.

 

Video #3: Dr. Marguerite McDonald

Marguerite McDonald, MD, of OCLI Vision, talks about the “highly effective” and “easy to tolerate” treatment for Demodex blepharitis.

 

 

Video #4: Dr. Renee Bovelle

Renee Bovelle, MD, of Envision Eye & Laser, takes patient feedback on symptoms they’re experiencing and explains that they have Demodex blepharitis and need to take eye drops for about 6 weeks.

 

Share

Related Content

  • Dry Eye

Spotlight on LACRIFILL®

  • Conference Roundup

If your patient has recurrent chalazia, consider co-occurring Demodex blepharitis

  • Conference Roundup

Ocular staining and dry mouth may help identify Sjögren’s-related dry eye

  • Conference Roundup

Daily vaping associated with increased risk of ocular surface disease

  • Conference Roundup

Nearly half of eye care providers show Demodex infestation, with severity increasing over time in practice

  • Conference Roundup

Higher Demodex burden linked to reduced lipid layer thickness in blepharitis

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon